rabies

Documents about rabies

• Survey of Human Rabies Immune Globulin Safety in Children#852369ClinicalTrials.gov
• Study of Purified Vero Rabies Vaccine and Rabies Human Diploid Cell Vaccine in a Simulated Rabies Post-exposure Regimen#311192ClinicalTrials.gov
• RNActive® Rabies Vaccine (CV7201) in Healthy Adults#429622ClinicalTrials.gov
• Comparison of SYN023 to Human Rabies Immune Globulin in Post Exposure Prophylaxis of Rabies#160181ClinicalTrials.gov
• Prevention of Rabies With Four Doses of Rabies Vaccine#864532ClinicalTrials.gov
• Survey on the current status of rabies post-exposure prophylaxis clinics construction and the surveillance of rabies-exposed individuals in China, 2022#302067PLOS
• Study of Purified Vero Rabies Vaccine Compared With a Reference Rabies Vaccine as Simulated Rabies Post-Exposure Prophylaxis in Adult and Pediatric Population in Thaïland#892248ClinicalTrials.gov
• Randomized Phase II Trial on Safety and Neutralizing Activity of CL184 and Rabies Vaccine Versus Human Rabies Immune Globulin (HRIG) and Rabies Vaccine in Children and Adolescents#120210ClinicalTrials.gov
• Purified Rabies Vaccine for Human Use (Chick-embryo Cell)#969082ClinicalTrials.gov
• Immune Responses After a Four-site Intradermal Rabies Booster Vaccination in HIV-infected Adults#877319ClinicalTrials.gov
• Boostability Assessment of Three Rabies Pre-Exposure Regimens in Healthy Volunteers 5 Years Following Priming.#833980ClinicalTrials.gov
• Safety and Immunogenicity of the Candidate Rabies Vaccine ChAdOx2 RabG#448321ClinicalTrials.gov
• Real-World Effectiveness of Zamerovimab and Mazorelvimab and Vaccine for Rabies Grade III Exposure in Nanyang#994146ClinicalTrials.gov
• Safety and Immunogenicity of ID vs IM Rabies Vaccine#454073ClinicalTrials.gov
• Safety, Pharmacokinetics, and Pharmacodynamic Testing of Rabies mAb CBB 1#459957ClinicalTrials.gov
• A Randomized Phase II Trial to Compare the Safety and Neutralizing Activity of CL184 in Combination With Rabies Vaccine vs. HRIG or Placebo in Combination With Rabies Vaccine in Healthy Adult Subjects#867912ClinicalTrials.gov
• Kinetics of rabies-neutralising antibodies in non-human primates after the injection of adjuvanted and inactivated rabies vaccine#280576HAL (France)
• The Safety Research of Freeze-dried Rabies Vaccine（MRC-5 Cell) in Chinese Humans#845708ClinicalTrials.gov
• Comparison of Purified Vero Rabies Vaccine, Serum Free With Human Diploid Cell Vaccine in Pre-exposure Use#874636ClinicalTrials.gov
• Rabies exposure in international travellers: Experience from a single travel clinic in Paris, France, 2018–2022#157695HAL (France)
• Immunogenicity of Rabies Vaccine for Pre Exposure Prophylaxis#873989ClinicalTrials.gov
• Diagnostic Immunization With Rabies Vaccine in Patients With PID#805903ClinicalTrials.gov
• Dosage-Escalation Study of the Safety and Immunogenicity of a Novel Rabies Vaccine ChAd155-RG vs. the Comparator RABAVERT Vaccine in Healthy Adult Subjects#160155ClinicalTrials.gov
• Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Pre-exposure Prophylaxis Regimen#125928ClinicalTrials.gov
• Immunogenicity and Safety Assessment of Rabies Vaccine (Vero Cell) for Human Use, Freeze-dried#184948ClinicalTrials.gov
• A Phase Ib/II Study of the Safety and Immunogenicity of the Candidate Rabies Vaccine ChAdOx2 RabG#195377ClinicalTrials.gov
• A Clinical Trial of Rabies Vaccine（Human Diploid Cell）for Human Use,Freeze-dried#390950ClinicalTrials.gov
• Safety and Tolerability of CV8102 Alone and in Combination With a Rabies Virus Vaccine in Healthy Adults#895834ClinicalTrials.gov
• Clinical Trial of Freeze-dried Human Rabies Vaccine (Without Serum Vero Cells)#967867ClinicalTrials.gov
• Perception of rabies among residents of selected local government areas of Oyo State, Nigeria#216189University of Ibadan Institutional Repository
• A Study to Assess the Safety, Reactogenicity and Immune Response of CureVac's Candidate Rabies mRNA Vaccine in Healthy Adults#307299ClinicalTrials.gov
• An mRNA Vaccine Encoding Rabies Virus Glycoprotein Induces Protection against Lethal Infection in Mice and Correlates of Protection in Adult and Newborn Pigs#403252OpenAlex
• Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Simulated Post-exposure Prophylaxis Regimen#383601ClinicalTrials.gov
• Protocol for a well-performed rabies post-exposure prophylaxis delivery: to read along with the decision trees 1- Wound risk assessment and 2 - PEP risk assessment#328618WHO IRIS
• A Phase III Clinical Trial on Immunogenicity and Safety of Lyophilized Rabies Vaccine for Human Use (Human Diploid Cell)#448309ClinicalTrials.gov
• A Clinical Trial of Freeze-dried Human Rabies Vaccine (Vero Cells)#623541ClinicalTrials.gov
• Rabies Treatment by Exposure of Patient to X-Ray#888970ClinicalTrials.gov
• Observation on the Immune Persistence of People Aged 10-60 Years Old Immunized With Five Doses of Rabies Vaccine#314381ClinicalTrials.gov
• A Phase 3 Clinical Trial for a Rabies Vaccine (Vero Cell) for Human Use in Healthy Chinese Subjects#332802ClinicalTrials.gov
• A Clinical Trial of Freeze-dried Human Rabies Vaccine (MRC-5 Cells)#865679ClinicalTrials.gov
• A Clinical Trial of Rabies Vaccine（Human Diploid Cell）for Human Use,Freeze-dried in a Population Aged 10-60 Years#256961ClinicalTrials.gov
• The rise and fall of rabies in Japan: A quantitative history of rabies epidemics in Osaka Prefecture, 1914–1933#657727CGSpace
• Dog Owners' Willingness to Pay for Rabies Vaccine and Associated Factors in Selected Zones of Amhara Region, Ethiopia.#358755PubMed
• The Post-Marketing Safety and Immunogenicity Research of Speeda® Rabies Vaccine for Human Use#804176ClinicalTrials.gov
• Rabies prevention and control in the WHO African Region#286817World Health Organization
• A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccine for the Prevention of Yellow Fever, and of an Investigational Vaccine for the Prevention of Rabies, in Healthy Adults#180225ClinicalTrials.gov
• Safety and Immune Response of a Rabies Vaccine With the Essen Schedule and a Two-Dose Booster#829147ClinicalTrials.gov
• Optimising human rabies vaccine supply chains: A modelling study#155941PMC Full-Text (OAI)
• Paralytic rabies outbreak mimicking guillain–Barré syndrome in French Amazonia#156441HAL (France)
• A Child Surviving Rabies in Tunisia: A Case Report#414963HAL (France)